Featured Stories

On May 22, 2020, Kintor Pharmaceutical Limited (stock code: 9939. HK) was officially listed on the Hong Kong Stock Exchange. We medicilon extend the congratulations and best wishes. Medicilon has joined hands with in multiple pharmaceutical development projects in recent years, including external preclinical pharmacokinetic studies and safety evaluation of the androgen receptor antagonist FrestatinRead more

Zhangjiang Runhe International Office Garden Opened On April 15, 2020, the opening ceremony of Zhangjiang Runhe International Office Garden was successfully held.  The Member of the Standing Committee and Deputy Mayor of Shanghai Municipal Committee, Qing Wu, led several of the Shanghai government officials and business representatives attended the ceremony. Zhangjiang Runhe International Office GardenRead more

On April 10th 2020, the Deputy Mayor of Shenzhen Municipal Government Nie Xinping and his team visited Medicilon for the research.  Dr. Chunlin Chen, Founder & CEO of Medicilon, accompanied the research and report. During the visiting for the research, Dr. Chen introduced the 16 years of development history of Medicilon, a one-stop preclinical newRead more

A national mourning period was held on Saturday, this year’s Tomb Sweeping Day, to commemorate those who succumbed to COVID-19. To express profound condolences to martyrs who sacrificed their lives in fighting the novel coronavirus disease and compatriots who died of the pathogen, national flags will be lowered to half-mast across the country and atRead more

On March 10, 2020, PA1010 tablets, which are independently developed by Zhejiang Bolaatu Medical Technology Co., Ltd, obtained the implied license for NMPA clinical trials. This is the first new drug declared by Bolaatu.  PA1010 is a new class I drug for chronic hepatitis B (CHB). Zhejiang Bolaatu is a new drug research and developmentRead more